This product is a box of 10 vials.
What Is GLOWÂ ?
Combined research on BPC-157, TB-500, and GHK-Cu may offer enhanced tissue regeneration and anti-inflammatory benefits by activating multiple repair pathways at the same time:
- Angiogenesis: TB-500 and BPC-157 both promote vascularization through VEGF, while GHK-Cu boosts the growth of endothelial cells.
- Cellular migration and matrix remodeling: TB-500 improves actin polymerization and cell movement; GHK-Cu and BPC-157 stimulate the production of extracellular matrix and fibroblast activity.
- Anti-inflammatory modulation: All three reduce oxidative stress and inflammation driven by cytokines, which could lead to better healing in chronic or complex injuries.
This combined synergy suggests greater effectiveness in areas like musculoskeletal issues, skin conditions, and recovery after surgery.
Chemical Diagrams:
Compound 1: TB-500
Sequence: Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser
Molecular formula: C212H350N56O78S
Molar Mass: 4963.4408
CAS number: 77591-33-4
PubChem: CID 16132341
Compound 2: BPC-157
Sequence: Gly- Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Molecular Formula: C62H98N16O22
Molecular Weight: 1419.556 g/mol
PubChem CID: 108101
Compound 3: GHK-Cu
Sequence:Â Gly-His-Lys.Cu.xHAc
Molecular Formula:Â C14H23CuN6O4
Molecular Weight: 401.91 g/mol
PubChem CID:Â 73587
CAS Number:Â 89030-95-5
Biochemistry
TB500 is a synthetic peptide derived from thymosin beta-4 (TB-4), a naturally occurring protein in the human body known for its anti-inflammatory and tissue-repairing properties. Like TB-4, TB500 binds to actin and plays a role in gene regulation. It has shown benefits across various systems, including cardiovascular health, muscle regeneration, immune modulation, and central nervous system function. TB500 has even been linked to promoting hair growth and easing some effects of aging.
TB500 operates through two primary mechanisms:
- Actin Sequestration and Cell Motility Regulation:Within cells, TB500 binds to and sequesters actin, a key component of the cytoskeleton. This interaction is crucial for regulating cell movement, growth, and division. By enhancing cell motility, TB500 supports faster wound healing, improved immune cell trafficking, reduced inflammation, and increased angiogenesis (blood vessel formation).
- Gene Expression Modulation ("Moonlighting" Function): Beyond its structural role, TB500 also influences gene expression independent of actin binding. It modulates the expression of genes involved in nitric oxide (NO) production, angiogenesis, and cellular proliferation—paralleling several downstream effects observed with BPC-157. Through this regulatory function, TB500 affects cytokine secretion and modulates multiple signaling pathways associated with the inflammatory response. Notably, it downregulates pathways such as NF-κB and Toll-like receptor signaling, thereby suppressing pro-inflammatory cytokines like TNF-α and IL-1 receptor-associated kinases.
In addition to controlling inflammation, TB500 activates several tissue repair pathways, including PI3K/Akt/eNOS, Notch, and angiopoietin-1/Tie signaling. One of its most studied actions involves modulation of the TGF-β pathway, which plays a central role in reducing fibrosis (scarring)—making TB500 particularly valuable in the context of chronic injury and tissue regeneration.
As an aside, there is research to show that TB500 influences Wnt signaling. This has been shown to promote the formation of hair follicles and boost hair growth at the level of DNA expression patterns. The diagram below offers an overview of the complex and wide-ranging influences of TB500.
BPC-157 is a synthetic peptide made of 15 amino acids. It comes from a naturally occurring compound in the body known as Body Protective Compound (BPC). Originally isolated from human gastric juice, BPC has shown strong anti-inflammatory and wound-healing properties. In animal studies, BPC-157 has shown potential tissue regeneration benefits across various systems, including the gastrointestinal tract, liver, pancreas, ligaments, muscles, tendons, cornea, heart, brain, and nerves.
While the exact way BPC-157 works is not fully clear, several ideas have emerged. It is not yet known if the peptide acts by binding to cell surface receptors or by entering cells and directly influencing genetic activity. In truth, BPC-157 may work through both methods.
Research has consistently shown that BPC-157 greatly affects nitric oxide (NO) signaling—particularly through its regulation of endothelial nitric oxide synthase (eNOS). This is believed to explain many of its therapeutic effects because NO promotes the movement of vascular endothelial cells that are important in tissue repair and the growth of new blood vessels. There is recent evidence showing that BPC-157 promotes the phosphorylation of Src, Cav-1, and eNOS. It also reduces the binding interaction between Cav-1 and eNOS, an essential step in eNOS activation and NO production.
BPC-157 is known for its rapid absorption and spread throughout the body when taken by mouth or injected. Within 10 minutes of injection, the peptide is detectable throughout the body, including the kidneys, liver, stomach wall, thymus, reproductive organs, and spleen. Peak concentrations in tissues are typically reached about one hour after administration and gradually decline over the following 48 hours. The highest levels are usually found in the kidney, liver, thymus, and spleen, with moderate distribution in the lungs, muscles, brain, and skin.
Many of BPC-157's effects are thought to occur through changes in gene expression patterns. Again, the mechanism for this is not fully understood, but the peptide has been shown to clearly alter the expression patterns of:
• Egr,
• Nos (especially eNos),
• Srf,
• Vegr,
• Plcγ, and
• Kras.
These genes control the synthesis of a number of factors that affect cells of blood vessels and the immune system. BPC-157 has been shown to alter fundamental properties of cells like migration, adhesion, thrombosis, and inflammatory responses. These alterations result in changes to cell behavior that help regulate inflammation and improve tissue healing. Additional research shows that expression levels of each gene are increased or decreased based on the timeframe following administration of BPC-157. In other words, the length of time that BPC-157 is in the system is important in determining which genes are activated. This suggests that BPC-157 works through a complex regulatory mechanism that has fine control over a wide array of genes and their expression.
GHK-Cu is a naturally occurring copper complex made of a short peptide (GHK) bound to copper(II) ions. Initially isolated from human plasma, it has also been detected in saliva and urine. Animal studies have shown that GHK-Cu plays a significant role in wound healing and modulating inflammatory responses. It is particularly known for its ability to stimulate collagen production and promote the growth of skin fibroblasts, which has led to its widespread use in cosmetic formulations as an anti-aging compound.
GHK-Cu exerts its effects largely by regulating the activity of key enzymes involved in tissue remodeling. It stimulates the production of metalloproteinases, enzymes that break down damaged proteins to facilitate tissue repair. At the same time, it promotes the expression of anti-proteases, which help preserve healthy proteins from degradation. Much like BPC-157, GHK-Cu appears to orchestrate a delicate balance between protein synthesis and breakdown through gene regulation, supporting a highly coordinated wound healing process—especially within the skin and connective tissue.
GLOW Anti-Inflammatory Effects
After covering the basics of how BPC-157, TB500, and GHK-Cu work, it's key to explore their benefits and why combining them might lead to stronger results. The main shared property is controlling inflammation to guide better healing.
Of the three, BPC-157 has the clearest anti-inflammatory effects. Studies repeatedly show it calms excessive inflammation. Chronic inflammation, causing pain and disability, is basically a loss of control over normal inflammation. BPC-157 seems great at restoring that control. Recent research found it almost fully eliminates inflammation in interstitial cystitis, a bladder condition once thought incurable.
BPC-157 regulates nitric oxide production as a key anti-inflammatory action. Nitric oxide is vital for inflammation, controlling blood vessel dilation, immune responses by cells like macrophages, cytokine release, tissue repair, and more. It's especially important in the nervous system, where NO imbalances link to neurodegenerative diseases.
Unlike BPC-157, TB500 regulates inflammation by blocking cytokines like TNF-α and interleukin-6. These cytokines start and sustain inflammation and are targets for drugs like Remicade and Humira, used for inflammatory bowel disease, rheumatoid arthritis, psoriasis, and other autoimmune conditions.
Together, these two peptides tackle inflammation from different sides, possibly leading to better control even at low doses. Low doses mean more benefits with fewer side effects. Adding GHK-Cu could create even more synergy, as its anti-inflammatory effects overlap with both. GHK-Cu scavenges free radicals and interacts with nitric oxide to prevent its negatives. Excess NO can create free radicals and tissue damage, so GHK-Cu reduces that risk.
GHK-Cu also suppresses TNF-α and interleukin-6, boosting TB500's effects while letting TB500 focus on blood vessel growth and cell proliferation. This shifts TB500 toward wound healing over inflammation reduction, speeding up overall recovery. Once healing finishes, inflammation isn't needed, so GHK-Cu likely shortens healing time by freeing TB500 for repair.
GLOW: Tissue Repair
Tissue repair covers many areas, from skin cuts to diabetic ulcers, muscle tears to tendon ruptures. These peptides act as general healers, aiding repair almost everywhere in the body. Combined, they could speed recovery from injuries or surgery.
BPC-157 is strong for wound healing, speeding the process from start to finish and improving repair structure. In tendon studies, it greatly enhances long-term outcomes, like better mobility after repair. It can cut recovery time by up to 80% on its own.
BPC-157 has many wound-healing effects, detailed in its dedicated page. For this blend, focus on how it boosts growth hormone receptor expression on fibroblasts, the main cells for tissue repair. Growth hormone speeds repair but can cause side effects like abnormal bone growth or heart issues. BPC-157 solves this by increasing GH receptors locally at injury sites, providing benefits without systemic side effects.
Fibroblasts drive wound healing, and BPC-157 supercharges them with more GH receptors. TB500 further stimulates these fibroblasts by increasing collagen deposition, building scaffolding for blood vessels and tissue. TB500 also activates satellite cells, stem cells that become repair cells. With more collagen, matrix, and new cells, healing happens fast.
Healing creates waste like free radicals, which damage cells and matrix. GHK-Cu improves antioxidant responses to reduce this damage, keeping inflammation low. Reducing free radicals limits scarring, improving outcomes. In short, GHK-Cu preserves BPC-157 and TB500's benefits while cutting damage from fast healing.
GLOW Anti-Bacterial Properties
These peptides' anti-bacterial effects could fit under wound healing, as preventing bacterial growth is key to quick, successful repair. But their strong anti-bacterial traits deserve separate attention.
TB500 limits microbial growth in several ways. It has direct anti-microbial properties against bacteria and fungi. More importantly, it improves antibiotic penetration into tissues, raising antimicrobial levels where needed.
GHK-Cu reduces wound infections differently. It cuts infection rates by 27% by combining with fatty acids from damaged tissue to form an anti-microbial mix against bacteria and fungi. This differs from TB500 and likely works together to create a microbe-hostile environment.
BPC-157 lacks direct anti-microbial action but supports it by boosting blood supply to wounds. This increases immune cell delivery to fight infection and removes debris that could encourage microbes.
GLOW Anti-Aging Effects
Combined, the tissue repair and anti-inflammatory benefits of BPC-157, TB500, and GHK-Cu give them strong anti-aging properties. The body maintains itself through ongoing repair and rebuilding, but these slow with age. That's why recovery takes longer, and we're more prone to infections, heart disease, and brain decline. Aging often stems from failing repair processes and rising inflammation. Boosting repair and controlling inflammation could slow or reverse aging. This explains the popularity of antioxidants, exercise, and diet—focusing on recovery over injury causes. Below is how each peptide fights aging.
TB500 is studied for regenerative therapies against age-related decline. Most adult organs, like the heart and brain, regenerate poorly. Heart muscle cells renew at just 0.5%–2%, too low for recovery from attacks or aging loss. TB500 aids cardiac cell migration and survival in embryos. In adults, it boosts myocyte survival and heart function after artery blockage, activating epicardial progenitors for repair. Harnessing this could reduce cardiovascular disease, a top global killer.
TB500 has clear anti-inflammatory effects. Monocytes produce TB500 sulfoxide with glucocorticoids, blocking neutrophil movement and inflammation. It supports cell survival by reducing cytochrome c release, raising BCL-2, and lowering caspase activity—key in sepsis, where it reduces inflammation and F-actin buildup in vessels.
TB500 aids eye healing (like corneal wounds or infections) and skeletal muscle regeneration. Phase 2 trials show it treats chronic skin wounds like pressure ulcers and epidermolysis bullosa. It's safe, well-tolerated, and promising for regeneration.
Like TB500, BPC-157 benefits the heart by improving blood flow to cells, lowering pressure, and reducing clotting that causes attacks. In mice, it cuts necrosis markers and limits heart damage. BPC-157 prevents more harm while TB500 repairs, reducing long-term effects. It offers similar benefits in the nervous system, gut, kidneys, bladder, muscles, and bones—as a universal healer reducing inflammation and boosting regeneration.
GHK-Cu suppresses NFκB, boosts DNA repair enzymes, and enhances proteasome cell-cleaning. These improve heart repair while preventing initial damage. GHK-Cu affects about 32% of human genes, suppressing harmful ones for inflammation and breakdown while boosting repair ones.
GHK-Cu cuts oxidative stress by neutralizing reactive oxygen species (ROS) and cytokines like TNF-α and IL-6. It clears toxic lipid byproducts linked to diabetes and brain decline. In animals, it reduces brain inflammation and may modulate epigenetic paths for cognitive issues.
Copper imbalances link to diseases like Alzheimer’s, Parkinson’s, and Wilson’s. GHK-Cu regulates brain copper, preventing amyloid beta buildup in Alzheimer’s. It may not reverse plaques but could prevent them.
Imagine combining these anti-aging effects for synergy beyond individual benefits. With body-wide applications, this blend could boost not just lifespan but overall health.
Curious about GLOW Blend?
Join our Facebook group to engage directly with thousands of others who use this product, and follow our Facebook/IG pages for hot updates and product announcements!
